Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]

BACKGROUND: Prophylactic treatment with N-acetylcysteine (NAC) for 3 months or more is associated with a reduction in the frequency of exacerbations of chronic obstructive pulmonary disease (COPD). This raises the question of whether treatment with NAC during an acute exacerbation will hasten recove...

Descripción completa

Detalles Bibliográficos
Autores principales: Black, Peter N, Morgan-Day, Althea, McMillan, Tracey E, Poole, Phillippa J, Young, Robert P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539269/
https://www.ncbi.nlm.nih.gov/pubmed/15581425
http://dx.doi.org/10.1186/1471-2466-4-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539269/
https://www.ncbi.nlm.nih.gov/pubmed/15581425
http://dx.doi.org/10.1186/1471-2466-4-13

Ejemplares similares